Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Impaired natural killer cell subset phenotypes in human obesity.

Bähr I, Jahn J, Zipprich A, Pahlow I, Spielmann J, Kielstein H.

Immunol Res. 2018 Apr;66(2):234-244. doi: 10.1007/s12026-018-8989-4.

2.

Significantly enhanced lung metastasis and reduced organ NK cell functions in diet-induced obese rats.

Spielmann J, Hanke J, Knauf D, Ben-Eliyahu S, Jacobs R, Stangl GI, Bähr I, Kielstein H.

BMC Obes. 2017 Jul 3;4:24. doi: 10.1186/s40608-017-0161-5. eCollection 2017.

3.

Diet-Induced Obesity Is Associated with an Impaired NK Cell Function and an Increased Colon Cancer Incidence.

Bähr I, Goritz V, Doberstein H, Hiller GG, Rosenstock P, Jahn J, Pörtner O, Berreis T, Mueller T, Spielmann J, Kielstein H.

J Nutr Metab. 2017;2017:4297025. doi: 10.1155/2017/4297025. Epub 2017 Mar 5.

4.

Public-Private Partnerships in Lead Discovery: Overview and Case Studies.

Gottwald M, Becker A, Bahr I, Mueller-Fahrnow A.

Arch Pharm (Weinheim). 2016 Sep;349(9):692-7. doi: 10.1002/ardp.201600078. Epub 2016 Jun 23. Review.

PMID:
27335205
5.

Decreased NK cell functions in obesity can be reactivated by fat mass reduction.

Jahn J, Spielau M, Brandsch C, Stangl GI, Delank KS, Bähr I, Berreis T, Wrann CD, Kielstein H.

Obesity (Silver Spring). 2015 Nov;23(11):2233-41. doi: 10.1002/oby.21229. Epub 2015 Sep 22.

6.

Experimental and clinical aspects of melatonin and clock genes in diabetes.

Peschke E, Bähr I, Mühlbauer E.

J Pineal Res. 2015 Aug;59(1):1-23. doi: 10.1111/jpi.12240. Epub 2015 Jun 6. Review.

PMID:
25904189
7.

Melatonin and pancreatic islets: interrelationships between melatonin, insulin and glucagon.

Peschke E, Bähr I, Mühlbauer E.

Int J Mol Sci. 2013 Mar 27;14(4):6981-7015. doi: 10.3390/ijms14046981. Review.

8.

Evidence of the receptor-mediated influence of melatonin on pancreatic glucagon secretion via the Gαq protein-coupled and PI3K signaling pathways.

Bähr I, Mühlbauer E, Albrecht E, Peschke E.

J Pineal Res. 2012 Nov;53(4):390-8. doi: 10.1111/j.1600-079X.2012.01009.x. Epub 2012 Jun 4.

PMID:
22672634
9.

GLUT4 in the endocrine pancreas--indicating an impact in pancreatic islet cell physiology?

Bähr I, Bazwinsky-Wutschke I, Wolgast S, Hofmann K, Streck S, Mühlbauer E, Wedekind D, Peschke E.

Horm Metab Res. 2012 Jun;44(6):442-50. doi: 10.1055/s-0032-1306335. Epub 2012 Apr 5.

PMID:
22488520
10.

High-mobility group A1 protein: a new coregulator of peroxisome proliferator-activated receptor-γ-mediated transrepression in the vasculature.

Bloch M, Prock A, Paonessa F, Benz V, Bähr IN, Herbst L, Witt H, Kappert K, Spranger J, Stawowy P, Unger T, Fusco A, Sedding D, Brunetti A, Foryst-Ludwig A, Kintscher U.

Circ Res. 2012 Feb 3;110(3):394-405. doi: 10.1161/CIRCRESAHA.111.253658. Epub 2011 Dec 29.

PMID:
22207709
11.

High-dose treatment with telmisartan induces monocytic peroxisome proliferator-activated receptor-γ target genes in patients with the metabolic syndrome.

Bähr IN, Tretter P, Krüger J, Stark RG, Schimkus J, Unger T, Kappert K, Scholze J, Parhofer KG, Kintscher U.

Hypertension. 2011 Oct;58(4):725-32. doi: 10.1161/HYPERTENSIONAHA.111.173542. Epub 2011 Aug 29.

PMID:
21876071
12.

The insulin-melatonin antagonism: studies in the LEW.1AR1-iddm rat (an animal model of human type 1 diabetes mellitus).

Peschke E, Hofmann K, Bähr I, Streck S, Albrecht E, Wedekind D, Mühlbauer E.

Diabetologia. 2011 Jul;54(7):1831-40. doi: 10.1007/s00125-011-2138-0. Epub 2011 Apr 15.

PMID:
21491159
13.

Melatonin stimulates glucagon secretion in vitro and in vivo.

Bähr I, Mühlbauer E, Schucht H, Peschke E.

J Pineal Res. 2011 Apr;50(3):336-44. doi: 10.1111/j.1600-079X.2010.00848.x. Epub 2011 Jan 18.

PMID:
21244480
14.

Chronic treatment with losartan results in sufficient serum levels of the metabolite EXP3179 for PPARgamma activation.

Kappert K, Tsuprykov O, Kaufmann J, Fritzsche J, Ott I, Goebel M, Bähr IN, Hässle PL, Gust R, Fleck E, Unger T, Stawowy P, Kintscher U.

Hypertension. 2009 Oct;54(4):738-43. doi: 10.1161/HYPERTENSIONAHA.109.132886. Epub 2009 Aug 17.

PMID:
19687349
15.

Off-target decoding of a multitarget kinase inhibitor by chemical proteomics.

Missner E, Bahr I, Badock V, Lücking U, Siemeister G, Donner P.

Chembiochem. 2009 May 4;10(7):1163-74. doi: 10.1002/cbic.200800796.

PMID:
19350611
16.

Crystallization and molecular-replacement solution of a diagnostic fluorescent dye in complex with a specific Fab fragment.

Hillig RC, Baesler S, Urlinger S, Stark Y, Bauer S, Badock V, Huber M, Bahr I, Schirner M, Licha K.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Mar 1;63(Pt 3):217-23. Epub 2007 Feb 23.

17.

Proteasomal degradation of the multifunctional regulator YB-1 is mediated by an F-Box protein induced during programmed cell death.

Lutz M, Wempe F, Bahr I, Zopf D, von Melchner H.

FEBS Lett. 2006 Jul 10;580(16):3921-30. Epub 2006 Jun 21.

18.

Binding of human serum amyloid P componentto L-selectin.

Stibenz D, Gräfe M, Debus N, Hasbach M, Bahr I, Graf K, Fleck E, Thanabalasingam U, Bührer C.

Eur J Immunol. 2006 Feb;36(2):446-56.

19.

The ubiquitin-specific protease USP10 modulates androgen receptor function.

Faus H, Meyer HA, Huber M, Bahr I, Haendler B.

Mol Cell Endocrinol. 2005 Dec 21;245(1-2):138-46. Epub 2005 Dec 20.

PMID:
16368182
20.

The interaction of protein kinase C isozymes alpha, iota, and theta with the cytoplasmic domain of L-selectin is modulated by phosphorylation of the receptor.

Kilian K, Dernedde J, Mueller EC, Bahr I, Tauber R.

J Biol Chem. 2004 Aug 13;279(33):34472-80. Epub 2004 Jun 10.

21.

Comparison of proteomic and genomic analyses of the human breast cancer cell line T47D and the antiestrogen-resistant derivative T47D-r.

Huber M, Bahr I, Krätzschmar JR, Becker A, Müller EC, Donner P, Pohlenz HD, Schneider MR, Sommer A.

Mol Cell Proteomics. 2004 Jan;3(1):43-55. Epub 2003 Oct 13.

22.

Identification of post-translationally modified proteins in proteome studies.

Sickmann A, Marcus K, Schäfer H, Butt-Dörje E, Lehr S, Herkner A, Suer S, Bahr I, Meyer HE.

Electrophoresis. 2001 May;22(9):1669-76.

PMID:
11425222
24.
25.

[Thermolabile characteristics of steroid hormone receptors in breast cancer].

Merkle E, Bähr I, Tulusan AH, Lang N.

Geburtshilfe Frauenheilkd. 1991 Mar;51(3):182-5. German.

PMID:
2055391
26.

[Long-term study of the significance of hormone receptors as prognostic factors in breast cancer].

Merkle E, Seidl I, Bähr I, Tulusan AH, von Maillot K, Sauerbrei KW, Wirtz PM.

Geburtshilfe Frauenheilkd. 1990 Jul;50(7):528-32. German.

PMID:
2391019
27.

[Prophylaxis of Rh-sensitisation by intravenous IgG anti-D (author's transl)].

Börner P, Deicher H, Bähr I, Chelius HH, Ghani G, Geldmacher H, Henke IW, Kindermann L, Marks V.

Dtsch Med Wochenschr. 1977 May 20;102(20):745-51. German.

PMID:
405190
28.

Supplemental Content

Support Center